Trial Profile
Wake up Symptomatic Stroke in Acute Brain Ischemia (WASSABI) Trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Alteplase (Primary) ; Aspirin/dipyridamole (Primary) ; Atorvastatin (Primary) ; Clopidogrel (Primary) ; Rosuvastatin (Primary) ; Antiplatelets; Aspirin
- Indications Embolism and thrombosis; Stroke
- Focus Therapeutic Use
- Acronyms WASSABI
- 29 Mar 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 26 Oct 2011 New trial record